Polyrizon Ltd
Research Polyrizon Ltd (PLRZ) on Bullrun: market cap USD 13.28M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerPLRZ
- ExchangeNASDAQ
- CountryIsrael
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 13.28M
- Financial periodFY2025
- Net income-USD 3.34M
- Free cash flow-USD 4.54M
Valuation Snapshot
latest market cap is USD 13.28M.
About Polyrizon Ltd
Polyrizon Ltd., a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel. The company uses its proprietary technology to develop its products comprising Capture and Contain, a barrier against a range of allergen particulates and viruses; and Trap and Target for nasal delivery of active pharmaceutical ingredients. It also develops PL-14, a nasal allergies blocker; and PL-16 for influenza blockers. Polyrizon Ltd.
Frequently asked questions
What is Polyrizon Ltd's market cap?
Polyrizon Ltd's market capitalization is USD 13.28M.
What does Polyrizon Ltd do?
Polyrizon Ltd., a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel. The company uses its proprietary technology to develop its products comprising Capture and Contain, a barrier against a range of allergen particulates and viruses;